[{"id":"74b84726-5dfa-4905-ad2e-aecfba9ada28","acronym":"","url":"https://clinicaltrials.gov/study/NCT02200978","created_at":"2021-01-18T10:17:32.797Z","updated_at":"2024-07-02T16:36:10.731Z","phase":"Phase 4","brief_title":"A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia","source_id_and_acronym":"NCT02200978","lead_sponsor":"South China Children's Leukemia Group","biomarkers":" PML","pipe":" | ","alterations":" RARA positive","tags":["PML"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RARA positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • methotrexate • mitoxantrone • arsenic trioxide • mercaptopurine"],"overall_status":"Completed","enrollment":" Enrollment 176","initiation":"Initiation: 09/01/2011","start_date":" 09/01/2011","primary_txt":" Primary completion: 10/01/2021","primary_completion_date":" 10/01/2021","study_txt":" Completion: 10/01/2021","study_completion_date":" 10/01/2021","last_update_posted":"2022-05-10"}]